Edition:
United Kingdom

Aimmune Therapeutics Inc (AIMT.OQ)

AIMT.OQ on NASDAQ Stock Exchange Global Select Market

22.61USD
8:59pm GMT
Change (% chg)

$-0.86 (-3.66%)
Prev Close
$23.47
Open
$23.41
Day's High
$23.80
Day's Low
$22.60
Volume
230,784
Avg. Vol
214,206
52-wk High
$41.75
52-wk Low
$21.38

Select another date:

Wed, Nov 28 2018

BRIEF-Aimmune Therapeutics Announces Closing Of $98 Mln Investment By Nestlé Health Science

* AIMMUNE THERAPEUTICS ANNOUNCES CLOSING OF $98 MILLION INVESTMENT BY NESTLÉ HEALTH SCIENCE

Nestle raises stake in food allergy drug developer Aimmune

The health science arm of Nestle SA will pay $98 million to raise its stake in Aimmune Therapeutics Inc, the drug developer said, as it prepares to submit a marketing application for its peanut allergy drug by the end of the year.

Nestle raises stake in food allergy drug developer Aimmune

The health science arm of Nestle SA will pay $98 million (76 million pounds) to raise its stake in Aimmune Therapeutics Inc , the drug developer said, as it prepares to submit a marketing application for its peanut allergy drug by the end of the year.

UPDATE 2-Nestle raises stake in food allergy drug developer Aimmune

Nov 12 The health science arm of Nestle SA will pay $98 million to raise its stake in Aimmune Therapeutics Inc, the drug developer said, as it prepares to submit a marketing application for its peanut allergy drug by the end of the year.

BRIEF-Aimmune Therapeutics Announces Additional Equity Investment By Nestlé Health Science

* AIMMUNE THERAPEUTICS ANNOUNCES ADDITIONAL EQUITY INVESTMENT BY NESTLÉ HEALTH SCIENCE

Nestle raises stake in food allergy drug developer Aimmune

Nov 12 The health science unit of Nestle SA would pay $98 million to increase its stake in Aimmune Therapeutics Inc, the drug developer for food allergies said on Monday.

Select another date: